Rotate your device

Please rotate your device to landscape mode
for the best experience.

Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Tranostat-MF Tablet

Prescription Icon
Prescription Required

Marketer

Ozone Pharmaceuticals Ltd

Salt Composition

Tranexamic Acid (500mg) + Mefenamic Acid (250mg)

Overview Tranostat-MF Tablet

Menadol-C is a combined medication indicated for managing heavy menstrual bleeding and associated pain. Its mechanism involves inhibiting clot breakdown to reduce excessive menstrual flow and suppressing the production of pain-inducing and inflammatory mediators. Menadol-C can be ingested with food at any time, but consistent daily timing is recommended. For optimal effectiveness, initiate treatment on the first day of menstruation. Continue taking the medication as directed by your physician. If a dose is missed, take it immediately upon recollection. Complete the entire prescribed course, regardless of symptom improvement. Report any lack of improvement in menstrual bleeding after three consecutive cycles. Common adverse reactions may include nausea, abdominal discomfort, headache, nasal congestion, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea is also possible; increased fluid intake is recommended to prevent dehydration. Consult your doctor if no menstrual changes are observed after three consecutive cycles. Prior to commencing treatment, disclose any kidney issues, vaginal bleeding disorders, or pregnancy/breastfeeding status. Inform your physician about any other medications you're currently using. Regular eye examinations may be requested during treatment. Alcohol consumption should be avoided while taking Menadol-C.

Primary Ingredients of Tranostat-MF Tablet

No text provided to rephrase.

Uses of Tranostat-MF Tablet

Managing excessive menstrual flow and menstrual discomfort

Major Benefits of Tranostat-MF Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tranostat-MF Tablets should be administered with a meal.

Common Side effects of Tranostat-MF Tablet:

  • Nausea
  • Vomiting
  • Heartburn
  • Indigestion
  • Diarrhea
  • Loss of appetite
  • Nasal congestion (stuffy nose)
  • Headache
  • Tiredness
  • Musculoskeletal (bone, muscle or joint) pain
  • Anemia (low number of red blood cells)
  • Stomach pain
  • Sinus pain
  • Sinus inflammation

How to use Tranostat-MF Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Tranostat-MF Tablet with a meal.

How Tranostat-MF Tablet works:

Tranexamic Acid and Mefenamic Acid, combined in Tranostat-MF Tablets, offer dual action for menstrual bleeding. Tranexamic Acid, an antifibrinolytic agent, stabilizes blood clots, reducing heavy menstrual flow. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits prostaglandin synthesis, alleviating associated pain and inflammation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Tranostat-MF Tablet with alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tranostat-MF Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Use of Tranostat-MF tablets while breastfeeding is likely safe. Available human data indicates minimal infant risk from the medication.

DrivingDrivingUNSAFE

Taking Tranostat-MF Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should use Tranostat-MF Tablets cautiously, potentially requiring dosage modification under medical supervision. Tranostat-MF Tablets are contraindicated in individuals with severe kidney disease.

LiverLiverSAFE IF PRESCRIBED

The use of Tranostat-MF Tablets in patients with liver disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, but physician consultation is recommended.

What if you forget to take Tranostat-MF Tablet :

Should you forget a Tranostat-MF Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Tranostat-MF Tablet

LabelValue
Developing Habits No.
Treatment Category KINSHIP
Tranostat-MF Tablet
328
MRP 380
13% off